Research Reports | Market Assessment
September 2017

Emerging Vaccines – Epidemiology – Vaccines Epidemiology Forecaster

The Vaccines Epidemiology Forecaster allows you to interactively assess assumptions about vaccine launch dates and the time taken to reach the current coverage of a particular vaccine group in a specified country in order to size the potential patient population a vaccine could reach.

QUESTIONS ANSWERED

  • What is the addressable market for vaccines in development, and how will that change over time?
  • What is the current coverage of a vaccine in a specific country?
  • What assumptions can I make for a new vaccine launch based on comparator products in a given country or region?

GEOGRAPHIES

  • Global, with additional granularity for the G7

EPIDEMIOLOGY

  • Patient population data by country or region and income status, with an algorithm to make extrapolations for missing data on vaccine coverage, based on similarities in GDP.

COVERAGE

  • Vaccine coverage includes: BCG, DTP, polio, hep B (birth dose), HPV, Japanese encephalitis, MCV, rota, yellow fever

DATA & FEATURES

  • Delivered as a stand-alone Excel model based on DRG’s gold-standard epidemiology for vaccine coverage.
  • G7 dashboard facilitates a more-granular analysis in the mature markets.
  • Options to incorporate additional primary or secondary data and customizable deliverables.
  • Access to DRG’s expert epidemiologists for bespoke support.

Table of contents

  • Emerging Vaccines - Epidemiology - Vaccines Epidemiology Forecaster
    • Introduction
      • Please Note:
      • Overview
Nishant Kumar, M.P.H.
Nishant Kumar, M.P.H.

Nishant Kumar, M.P.H., is a senior director on the Epidemiology team at Clarivate. His areas of expertise are oncology and CNS diseases, including Alzheimer’s disease and dementia. His key interests in oncology are modeling disease progression and drug-treatable incident and prevalent populations. Previously, Mr. Kumar sized patient populations for rare and niche diseases, such as graft-versus-host disease and Duchenne muscular dystrophy. He earned his M.P.H. with a concentration in epidemiology and statistics from King’s College in London and a B.Sc. (Honors) in medical studies from the University of Birmingham.

Login to access report
Back to all Market Assessment reports
Login to access report

launch Related Market Assessment Reports